Not Signed In - European Medicines Agency Adopts Positive Opinion Recommending Approval Of Xyrem(REG) For The Treatment Of Narcolepsy With Cataplexy In Adult Patients
Sat, 27 Jan 2007 02:00 PM EST
... UCB has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants marketing authorisation for Xyrem(REG) (sodium oxybate) in the treatment of narcolepsy with cataplexy in adult patients. [click link for full article] ...
Related Topics
- Narcolepsy
- Sodium Oxybate
- Foster Care
- Tb
- Older Adults
- Vaccine Testing & Approval
- Incontinence
- Children Of Alcoholics
- WISE EARS!® At Work!
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Atherosclerosis
- WISE EARS!® Campaign to Prevent NIHL
- WISE EARS!® Tips: Hearing Matters
- Smoking Cessation and Continued Risk in Cancer Patients
- Black Alder
- Acne
- Aging
- Over-the-Counter Medicines
- Asperger Syndrome
email this page
print this page
bookmark this page
feedback on this page
